Cargando…
Clinical Validation of AdvanSure GenoBlot Assay as Primary Screening and Test of Cure for Human Papillomavirus Infection
BACKGROUND: Clinical specificity and sensitivity are essential factors in the adoption of a human papillomavirus (HPV) test as a primary screening tool and test of cure after treatment of cervical cancer and precancerous lesions (High-Risk-Lesion). Using histologically-confirmed High-Risk-Lesion-pat...
Autores principales: | Kahng, Jimin, Oh, Eun-Jee, Lee, Hae Nam, Lee, Dae Woo, Kim, Yonggoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948825/ https://www.ncbi.nlm.nih.gov/pubmed/24624348 http://dx.doi.org/10.3343/alm.2014.34.2.127 |
Ejemplares similares
-
Allergen Microarrays for In Vitro Diagnostics of Allergies: Comparison with ImmunoCAP and AdvanSure
por: Jeon, Hyunjin, et al.
Publicado: (2018) -
Comparison of the AdvanSure™ real-time RT-PCR and Seeplex(®) RV12 ACE assay for the detection of respiratory viruses
por: Jung, Yu Jung, et al.
Publicado: (2015) -
Comparison of the ImmunoCAP Assay and AdvanSure™ AlloScreen Advanced Multiplex Specific IgE Detection Assay
por: Park, Kyung Hee, et al.
Publicado: (2017) -
Comparison of the AdvanSure RV Plus Real-Time RT-PCR and Real-Q RV II Detection Assays for Respiratory Viruses
por: Chung, Yoo Na, et al.
Publicado: (2021) -
Assessment of the Quantitative Ability of AdvanSure TB/NTM Real-Time PCR in Respiratory Specimens by Comparison with Phenotypic Methods
por: Lee, Hyeyoung, et al.
Publicado: (2014)